Clinical trial
Rituximab and Denileukin Diftitox in Treating Patients With Previously Untreated…
NCT00460109 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00460109 |
|---|---|
| Title | Rituximab and Denileukin Diftitox in Treating Patients With Previously Untreated Stage III or Stage IV Follicular B-Cell Non-Hodgkin's Lymphoma |
| Official title | A Phase II Clinical Trial of Denileukin Diftitox in Combination With Rituximab in Previously Untreated Follicular B-Cell Non-Hodgkin's Lymphoma |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Biological |
| Interventions | denileukin diftitox, rituximab |
| Enrollment | 24 |
| Start date | Apr 1, 2008 |
| Primary completion | Oct 1, 2010 |
| Completion | Mar 1, 2011 |
| First posted | Apr 13, 2007 |
| Last update posted | Apr 18, 2017 |
| Countries | United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: